Here, the focus is on studying the genetics of diseases that particularly afflict the Chinese population, such as hepatocellular carcinoma, a form of liver cancer.
Salt Lake City-based Myriad Genetics mygn (nasdaq: mygn - news - people) has been finding genes in a Mormon population in its hometown since its inception in 1991.